The actinomycete DEM20745, collected from non-rhizosphere soil adjacent to Paraserianthes falactaria trees (Cangkringan, Indonesia), is an efficient producer of the anticancer ansamycin polyketide 17-O-demethyl-geldanamycin (17-O-DMG), a biosynthetic precursor of the Hsp90 inhibitor geldanamycin (GDM). In DEM20745, 17-O-DMG is the major ansamycin product observed reaching a maximum titre of 17 mg/L in the fermentation broth. 17-O-DMG has the potential to be a key starting material for the semi-synthesis of GDM analogues for use in anticancer therapy. Thus, this preferential biosynthesis of 17-O-DMG facilitates easy access to this important molecule and provides further insight in the biosynthesis of the geldanamycins.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/14786419.2016.1263854 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A plug-and-play system for polycyclic tetramate macrolactam production and functionalization.
Microb Cell Fact
January 2025
Chair of Technical Biochemistry, Technische Universität Dresden, Bergstraße 66, 01069, Dresden, Germany.
Background: The biosynthesis of the natural product family of the polycyclic tetramate macrolactams (PoTeMs) employs an uncommon iterative polyketide synthase/non-ribosomal peptide synthetase (iPKS/NRPS). This machinery produces a universal PoTeM biosynthetic precursor that contains a tetramic acid moiety connected to two unsaturated polyene side chains. The enormous structural and hence functional diversity of PoTeMs is enabled by pathway-specific tailoring enzymes, particularly cyclization-catalyzing oxidases that process the polyene chains to form distinct ring systems, and further modifying enzymes.
View Article and Find Full Text PDFACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Am J Gastroenterol
September 2024
Division of Gastroenterology, VA San Diego Healthcare System, Division of Gastroenterology, University of California San Diego, San Diego, California, USA.
Helicobacter pylori is a prevalent, global infectious disease that causes dyspepsia, peptic ulcer disease, and gastric cancer. The American College of Gastroenterology commissioned this clinical practice guideline (CPG) to inform the evidence-based management of patients with H. pylori infection in North America.
View Article and Find Full Text PDFFactors associated with Helicobacter pylori antimicrobial resistance in a US pediatric cohort.
J Pediatr Gastroenterol Nutr
January 2025
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts, USA.
Article Synopsis
- A study was conducted to explore the epidemiological factors associated with antimicrobial resistance in US children infected with Helicobacter pylori from 2015 to 2022.
- Out of 273 patients, 43.2% showed resistance to at least one antimicrobial, with clarithromycin being the most common.
- Findings indicated that resistance varied by race and socioeconomic status, with Asian children having a higher resistance rate compared to white children, and lower household income linked to greater metronidazole resistance.
Diagnostic Challenges of Multiple Sporotrichoid Skin Lesions Caused by Mycobacterium marinum.
Am J Case Rep
November 2024
Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Article Synopsis
- Mycobacterium marinum is a slow-growing mycobacterium that can cause skin infections, often linked to aquatic environments and affecting even healthy individuals.
- A 23-year-old aquarium worker developed chronic skin nodules, initially misdiagnosed as tuberculosis; further biopsy confirmed M. marinum infection, leading to an adjustment in his treatment plan due to liver issues and side effects.
- The case highlights the importance of repeated biopsies for accurate diagnosis and the complexities involved in treating infections like M. marinum, as treatment regimens are not well-established and may require trial and error.
A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus.
J Appl Microbiol
November 2024
Center for Microbiology, VIB-KU Leuven, 3001 Leuven, Belgium.
Aims: We aimed to investigate the molecular mechanisms underlying the survival of Mycobacterium abscessus when faced with antibiotic combination therapy. By conducting evolution experiments and whole-genome sequencing (WGS), we sought to identify genetic variants associated with stress response mechanisms, with a particular focus on drug survival and resistance.
Methods And Results: We conducted evolution experiments on M.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!